Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 2
1989 1
1990 6
1991 2
1992 5
1993 5
1994 7
1995 4
1996 7
1997 6
1998 4
1999 4
2000 7
2001 8
2002 9
2003 14
2004 7
2005 4
2006 6
2007 11
2008 4
2009 2
2010 3
2011 6
2012 3
2013 9
2014 18
2015 13
2016 12
2017 10
2018 11
2019 9
2020 18
2021 11
2022 4
2023 10
2024 11
2025 12
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

254 results

Results by year

Filters applied: . Clear all
Page 1
Accuracy Is Everything?
Ginter PS, Hoda SA. Ginter PS, et al. Among authors: hoda sa. Am J Clin Pathol. 2021 Aug 4;156(3):331-333. doi: 10.1093/ajcp/aqaa232. Am J Clin Pathol. 2021. PMID: 33899082 No abstract available.
Mammary pilar metaplasia.
Stephan C, Demaria S, Hoda SA. Stephan C, et al. Among authors: hoda sa. Am J Clin Pathol. 2024 Aug 1;162(2):211-212. doi: 10.1093/ajcp/aqae026. Am J Clin Pathol. 2024. PMID: 38538079 No abstract available.
Author's reply.
Hoda SA, Prasad ML, Moore A, Hoda RS, Giri D. Hoda SA, et al. Histopathology. 2000 Nov;37(5):478. doi: 10.1046/j.1365-2559.2000.09739.x. Histopathology. 2000. PMID: 11119140 No abstract available.
Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition.
Madorsky Rowdo FP, Martini R, Ackermann SE, Tang CP, Tranquille M, Irizarry A, Us I, Alawa O, Moyer JE, Sigouros M, Nguyen J, Al Assaad M, Cheng E, Ginter PS, Manohar J, Stonaker B, Boateng R, Oppong JK, Adjei EK, Awuah B, Kyei I, Aitpillah FS, Adinku MO, Ankomah K, Osei-Bonsu EB, Gyan KK, Hoda S, Newman L, Mosquera JM, Sboner A, Elemento O, Dow LE, Davis MB, Martin ML. Madorsky Rowdo FP, et al. Among authors: hoda s. Cancer Res. 2025 Feb 1;85(3):551-566. doi: 10.1158/0008-5472.CAN-24-0775. Cancer Res. 2025. PMID: 39891928 Free PMC article.
Unbiased discovery of cancer pathways and therapeutics using Pathway Ensemble Tool and Benchmark.
Wang L, Pattnaik A, Sahoo SS, Stone EG, Zhuang Y, Benton A, Tajmul M, Chakravorty S, Dhawan D, Nguyen MA, Sirit I, Mundy K, Ricketts CJ, Hadisurya M, Baral G, Tinsley SL, Anderson NL, Hoda S, Briggs SD, Kaimakliotis HZ, Allen-Petersen BL, Tao WA, Linehan WM, Knapp DW, Hanna JA, Olson MR, Afzali B, Kazemian M. Wang L, et al. Among authors: hoda s. Nat Commun. 2024 Aug 24;15(1):7288. doi: 10.1038/s41467-024-51859-9. Nat Commun. 2024. PMID: 39179644 Free PMC article.
Adrenoleukodystrophy.
Chen X, DeLellis RA, Hoda SA. Chen X, et al. Among authors: hoda sa. Arch Pathol Lab Med. 2003 Jan;127(1):119-20. doi: 10.5858/2003-127-119-. Arch Pathol Lab Med. 2003. PMID: 12562281 Free article. No abstract available.
"Ossifying-type" mammary calcifications.
Resetkova E, Hoda SA. Resetkova E, et al. Among authors: hoda sa. Arch Pathol Lab Med. 2002 Aug;126(8):995-6. doi: 10.5858/2002-126-0995-OTMC. Arch Pathol Lab Med. 2002. PMID: 12197511 Free article. No abstract available.
Mammary Lymphangioma.
Arafah M, Sweet G, Ginter PS, Hoda SA. Arafah M, et al. Among authors: hoda sa. Int J Surg Pathol. 2015 Oct;23(7):542-3. doi: 10.1177/1066896915593800. Epub 2015 Jul 1. Int J Surg Pathol. 2015. PMID: 26135530 No abstract available.
Diagnostic Histopathology of Tumors.
Hoda SA, Hoda RS. Hoda SA, et al. Am J Clin Pathol. 2020 Nov 21:aqaa162. doi: 10.1093/ajcp/aqaa162. Online ahead of print. Am J Clin Pathol. 2020. PMID: 33219676 No abstract available.
Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment.
Madorsky Rowdo FP, Xiao G, Khramtsova GF, Nguyen J, Martini R, Stonaker B, Boateng R, Oppong JK, Adjei EK, Awuah B, Kyei I, Aitpillah FS, Adinku MO, Ankomah K, Osei-Bonsu EB, Gyan KK, Altorki NK, Cheng E, Ginter PS, Hoda S, Newman L, Elemento O, Olopade OI, Davis MB, Martin ML, Bargonetti J. Madorsky Rowdo FP, et al. Among authors: hoda s. Cancer Lett. 2024 Mar 1;584:216608. doi: 10.1016/j.canlet.2024.216608. Epub 2024 Jan 9. Cancer Lett. 2024. PMID: 38199587 Free PMC article.
254 results